Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Apr;44(4):1085-8.
doi: 10.1128/AAC.44.4.1085-1088.2000.

Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci

Affiliations
Comparative Study

Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci

D B Hoellman et al. Antimicrob Agents Chemother. 2000 Apr.

Abstract

GAR-936, a new glycylcycline, had lower MICs (< or =0.016 to 0.125 microg/ml) for 201 penicillin- and tetracycline-susceptible and -resistant pneumococcal strains than tetracycline (< or = 0.06 to 128 microg/ml), minocycline (< or =0.06 to 16.0 microg/ml), or doxycycline (< or =0.06 to 32.0 microg/ml). GAR-936 was also bactericidal against 11 of 12 strains tested at the MIC after 24 h, with significant kill rates at earlier time points.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Graphical depiction of GAR-936 kill kinetics versus a tetracycline-resistant (MIC, 64.0 μg/ml) strain of S. pneumoniae.

References

    1. Appelbaum P C. Antimicrobial resistance in Streptococcus pneumoniae—an overview. Clin Infect Dis. 1992;15:77–83. - PubMed
    1. Bergeron J, Ammirati M, Danley D, James L, Norcia M, Retsema J, Strick C A, Su W-G, Sutcliffe J, Wondrack L. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection. Antimicrob Agents Chemother. 1996;40:2226–2228. - PMC - PubMed
    1. Eliopoulos G M, Wennersten C B, Cole G, Moellering R C. In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrob Agents Chemother. 1994;38:534–541. - PMC - PubMed
    1. Goldstein F W, Kitzis M D, Acar J F. N,N-Dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci. Antimicrob Agents Chemother. 1994;38:2218–2220. - PMC - PubMed
    1. Hamilton-Miller J M T, Shah S. Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1996;37:1171–1175. - PubMed

Publication types

MeSH terms